First Trust Nasdaq Pharmaceuticals ETF
FTXH
6 hedge funds and large institutions have $1.2M invested in First Trust Nasdaq Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
129% more capital invested
Capital invested by funds: $524K → $1.2M (+$674K)
34.55% more ownership
Funds ownership: 25.3% → 59.84% (+35%)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$682K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$40.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$26K |
| 2 |
RAM
Riggs Asset Management
Dallas,
Pennsylvania
|
-$766 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.13M | +$682K | +33,811 | +149% |
|
|
2
Bank of America
Charlotte,
North Carolina
| $40K | +$40.5K | +2,007 | New |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $11K | – | – | – |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $10K | – | – | – |
|
|
IA
5
IFP Advisors
Tampa,
Florida
| $4K | – | – | – |
|
|
RAM
6
Riggs Asset Management
Dallas,
Pennsylvania
| $2K | -$766 | -38 | -25% |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$26K | -1,234 | Closed |
|
FTXH Hedge Fund Activity: Q3 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q3 2017, worth a combined $1.2M — up 129% from $524K a quarter earlier.
Fund positioning in FTXH was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $682K. The largest seller was UBS Group, exiting entirely with an estimated $26K sold.
- 6 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $1.2M of First Trust Nasdaq Pharmaceuticals ETF stock for Q3 2017, up 129% quarter-over-quarter.
- 1 fund opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q3 2017 and 1 closed out, a net change of 0 holders.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q3 2017 was Susquehanna International Group, an estimated $682K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q3 2017 was UBS Group, an estimated $26K sold.
Based on aggregated 13F filings for Q3 2017.